Intrascleral Drug Delivery to the Eye Using Hollow Microneedles

Pharmaceutical Research

Volumn 26, Issue 2, 2009, Pages 395-403

  Jiang, Jason ^a   Moore, Jason S ^a   Edelhauser, Henry F ^b   Prausnitz, Mark R ^a  

^a Georgia Institute of Technology   (United States)

^b EMORY EYE CENTER   (United States)

Author keywords

Eye; Hollow microneedle; MEMS; Ocular drug delivery; Sclera

Indexed keywords

COLLAGEN; COLLAGENASE; GLYCOSAMINOGLYCAN; HYALURONIDASE; NANOPARTICLE; SULFORHODAMINE B;

AQUEOUS SOLUTION; ARTICLE; CADAVER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HISTOLOGY; HUMAN; HUMAN TISSUE; NEEDLE; PRIORITY JOURNAL; SCLERA;

CADAVER; COLLAGENASES; EQUIPMENT DESIGN; FIBRILLAR COLLAGENS; GLYCOSAMINOGLYCANS; HUMANS; HYALURONOGLUCOSAMINIDASE; MICROINJECTIONS; NANOPARTICLES; NEEDLES; PARTICLE SIZE; PRESSURE; RHODAMINES; SCLERA;

EID: 58549106105     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-008-9756-3     Document Type: Article

References (30)

1. D. Ghate H. F. Edelhauser 2006 Ocular drug delivery Expert Opin. Drug Deliv. 3 275 287
2. E. M. Del Amo A. Urtti 2008 Current and future ophthalmic drug delivery systems. A shift to the posterior segment Drug Discov. Today 13 135 143
3. D. M. Maurice 2002 Drug delivery to the posterior segment from drops Surv. Ophthalmol. 47 Suppl 1 S41 52
4. R. D. Jager L. P. Aiello S. C. Patel E. T. Cunningham Jr 2004 Risks of intravitreous injection: a comprehensive review Retina 24 676 698
5. D. H. Geroski H. F. Edelhauser 2001 Transscleral drug delivery for posterior segment disease Adv. Drug Deliv. Rev. 52 37 48
6. S. H. Kim R. J. Lutz N. S. Wang M. R. Robinson 2007 Transport barriers in transscleral drug delivery for retinal diseases Ophthalmic. Res. 39 244 254
7. I. Fatt, and B. A. Weissman. Physiology of the Eye: An Introduction to the Vegetative Functions. Butterworth-Heinemann, Boston, 1992.
8. O. Weijtens E. J. Feron R. C. Schoemaker A. F. Cohen G. W. M. Lentjes F. P. H. T. M. Romijn J. C. v. Meurs 1999 High concentrations of dexamethasone in aqueous and vitreous after subconjunctival injection Am. J. Ophthamal. 1999 192 197
9. T. W. Lee J. R. Robinson 2001 Drug delivery to the posterior segment of the eye: some insights on the penetration pathways after subconjunctival injection J. Ocular Pharmacol. Ther. 17 565 572
10. S. B. Lee D. H. Geroski M. R. Prausnitz H. F. Edelhauser 2004 Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems Exp. Eye Res. 78 599 607
11. T. Yasukawa Y. Ogura H. Kimura E. Sakurai Y. Tabata 2006 Drug delivery from ocular implants Expert Opin. Drug Deliv. 3 261 273
12. E. Eljarrat-Binstock A. J. Domb 2006 Iontophoresis: a non-invasive ocular drug delivery J. Control Release 110 479 489
13. M. R. Prausnitz, H. S. Gill, and J.-H. Park. Microneedles for drug delivery. In M. J. Rathbone, J. Hadgraft, M. S. Roberts, and M. E. Lane (eds.), Modified Release Drug Delivery, Informa Healthcare, New York, 2008.
14. M. R. Prausnitz, J. A. Mikszta, M. Cormier, and A. K. Andrianov. Microneedle-based vaccines. Curr. Top Microbiol. Immunol. (2008, in press).
15. M. L. Reed W.-K. Lye 2004 Microsystems for drug and gene delivery Proc. IEEE. 92 56 75
16. W. Martanto J. S. Moore T. Couse M. R. Prausnitz 2006 Mechanism of fluid infusion during microneedle insertion and retraction J. Control Release 112 357 361
17. W. Martanto J. S. Moore O. Kashlan R. Kamath P. M. Wang J. M. O'Neal M. R. Prausnitz 2006 Microinfusion using hollow microneedles Pharm. Res. 23 104 113
18. H. Gill, D. Denson, B. Burris, and M. Prausnitz. Effect of microneedle design on pain in human subjects. Clin. J. Pain 24:585-594 (2008).
19. J. Jiang H. S. Gill D. Ghate B. E. McCarey S. R. Patel H. F. Edelhauser M. R. Prausnitz 2007 Coated microneedles for drug delivery to the eye Invest. Ophthalmol. Vis. Sci. 48 4038 4043
20. P. M. Wang M. Cornwell J. Hill M. R. Prausnitz 2006 Precise microinjection into skin using hollow microneedles J. Invest. Dermatol. 126 1080 1087
21. J. L. Bourges S. E. Gautier F. Delie R. A. Bejjani J. C. Jeanny R. Gurny D. BenEzra F. F. Behar-Cohen 2003 Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles Invest. Ophthalmol. Vis. Sci. 44 3562 3569
22. M. Raspanti M. Marchini V. Della Pasqua R. Strocchi A. Ruggeri 1992 Ultrastructure of the extracellular matrix of bovine dura mater, optic nerve sheath and sclera J. Anat. 181 Pt 2 181 7
23. T. W. Olsen S. Y. Aaberg D. H. Geroski H. F. Edelhauser 1998 Human sclera: thickness and surface area Am. J. Ophthalmol. 125 237 242
24. A. Edwards M. R. Prausnitz 1998 A fiber matrix model of sclera and corneal stroma for drug delivery to the eye AIChE J. 44 214 225
25. K. Friedman S. V. Pollack T. Manning S. R. Pinnell 1986 Degradation of porcine dermal connective tissue by collagenase and hyaluronidase Br. J. Dermatol. 115 403 408
26. ISTA Pharmaceuticals. Vitrase Package Insert, Irvine, CA, 2008.
27. S. Hayasaka S. Hara T. Shiono K. Mizuno 1980 Presence of lysosomal hyaluronidase in human corneoscleral tissue Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. 213 235 238
28. B. D. Kuppermann E. L. Thomas M. D. de Smet L. R. Grillone 2005 Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage Am. J. Ophthalmol. 140 585 597
29. Genentech. Lucentis Package Insert, South San Francisco, CA, 2008.
30. M. Gibson. Pharmaceutical Preformulation and Formulation: A Practical Guide from Candidate Drug Selection to Commerical Dosage Form. Informa Healthcare, New York, 2001.